| Term 
 | Definition 
 
        | Cholinoceptor Agonist Mech – acts directly
 Use – limited; miosis for eye surgery
 SFx – too much activation; short t1/2
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Agonist Mech – similar to Ach, but longer t1/2
 Use – dx of bronchiolar hypersensitivity; dx belladonna poisoning
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Agonist Mech – activates M and N receptors
 Use – topically in glaucoma to decrease intraocular pressure
 SFx – high doses = over-activation of M receptors on heart = cardiac arrest
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Agonist Mech – 100X potency of Ach; not destroyed by AchE, no N activity
 Use – pretty much just to poison people
 |  | 
        |  | 
        
        | Term 
 
        | Pilocarpine (isoptocarpine, salagen) |  | Definition 
 
        | Cholinoceptor Agonist Mech – primarily ophthalmic M3 effects; from leaves of S.American plant
 Use – topical for glaucoma and oral for xerostomia; opens canal of schlemm (narrow angle glaucoma); enhances tone of trabec. network (wide angle glau.); can also stimulate cortical neurons
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Agonist Mech – NM = muscle contractions; NN = ↑HR, vasoconstriction, ↑ gut motility, ↑ carotid body firing (↑ resp. rate), nausea and vomiting
 Use – smoking cessation
 SFx – contraindications = ulcers, GI disorders, asthma; drug interactions = antiarrhythmics, antidepressants
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Agonist Mech – short acting
 Use – dx myasthenia gravis from cholinergic crisis
 |  | 
        |  | 
        
        | Term 
 
        | Neostigmine / Pyridostigmine |  | Definition 
 
        | Cholinoceptor Agonist Mech – no CNS entry (quatranary amine)
 Use – Rx of ileus, urinary retention, reversal of NM blockers
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Agonist Mech – long-term; enters CNS
 Use – Rx for glaucoma, atropine overdose
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Agonist Mech – CNS entry
 Use – Rx for Alzheimer’s
 |  | 
        |  | 
        
        | Term 
 
        | Organophosphates (echothiophate, malathion, parathion, sarin) |  | Definition 
 
        | Cholinoceptor Agonist Mech – irreversible inhibitors of AchE; lipid soluble, long acting
 Use – echo = Rx for glaucoma; mala/para = insecticides; sarin = nerve gas
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Agonist Mech – predominately M3; not destroyed by AchE; no N action
 Use – reduce reflux; gastric emptying abnormalities; help in urine voidance
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Antagonist Mech – M antagonist; competes with Ach for binding on M receptors (M1, M2, and M3)
 Use – antispasmodic, antisecretory, AchE inhibitor overdose, antidiarrheal, ophthalmology; counteracts peripheral vasodilation from M agonists; does not affect BP; does not enter CNS; at high doses it ↓secretions, mydriasis, hyperthermia, tachycardia, sedation, urinary retention
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Antagonist Mech – nonselective M antagonist; mostly on bronchial M3; reduce bronchial secretions
 Use – COPD and asthma (decreases bronchiole constrictions and secretions)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Antagonist Mech – M receptors in brain; re-estanlish dopaminergic-cholinergic balance; parasymp effector sites; ↓GI motility/secretions, ↑HR
 Use – Parkinson’s disease
 |  | 
        |  | 
        
        | Term 
 
        | Hexamethonium / Mecamylamine |  | Definition 
 
        | Cholinoceptor Antagonist Mech – block N receptors (NN and NM)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Antagonist Mech – non-depolarizing NM blocker; small doses = block Na+ channels; high doses = they enter pores
 Use – ↓neuromuscular action during anesthesia; tracheal intubation; control of ventilation; tx of convulsions
 SFx – hypotension due to systemic histamine release; hyperkalemia; ↑interocular pressure; ↑intragastric pressure; muscle pain
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Antagonist Mech – depolarizing NM blocker; phase 1 = persistent depolarization, eventual paralysis (augmented by ACEIs); phase 2 = endplate repolarizes, but subsequent depolarizations are difficult
 Use – ↓neuromuscular action during anesthesia; tracheal intubation; control of ventilation; tx of convulsions
 SFx – hyperkalemia; ↑interocular pressure; ↑intragastric pressure; muscle pain
 nist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Antagonist Mech – block Ach synth; block CHT (choline transporter)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Antagonist Mech – block Ach synth; block VAT
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Antagonist Mech – block Ach synth; block Ach vesicle release
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Cholinoceptor Antagonist Mech – block Ach breakdown; AchE inhibitor
 |  | 
        |  | 
        
        | Term 
 
        | Phenyleprine (neo-synephrine) / Methoxamine |  | Definition 
 
        | Adrenergic agonist Mech – α1 selective agonist (vascular smooth muscle… ↑HR and TPR); α1 > α2 >>>>> β
 Use – antihypotensive, paroxysmal tachycardia, nasal decongestant
 |  | 
        |  | 
        
        | Term 
 
        | Clonidine (catapres) / α-Methyldopa (aldomet) |  | Definition 
 
        | Adrenergic agonist Mech – α2 selective agonist; ↓symp tone = ↓BP; α2 > α1 >>>>> β
 Use – for HTN
 SFx – dry mouth, sedation, hypotension
 |  | 
        |  | 
        
        | Term 
 
        | Apraclonidine (lodipine) / Brimonidine (alphagan) |  | Definition 
 
        | Adrenergic agonist Mech – α2 selective agonist; ↓symp tone = ↓aqueous humor
 Use – for glaucoma
 SFx – dry mouth, sedation
 |  | 
        |  | 
        
        | Term 
 
        | Metaproterenol (metaprel) |  | Definition 
 
        | Adrenergic agonist Mech – β2 selective agonist; relax bronchial smooth m., suppress leukotriene and histamine release in lungs, enhance mucociliary fxn, ↓microvascular permeability, inhibit phospholipase A2; COMT resistant
 Use – long-term COPD, acute bronchospasm
 SFx – tremor, restlessness, tachycardia, ↑plasma glucose/lactate/FFAs, ↓plasma K+
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic agonist Mech – β2 selective agonist; relax bronchial smooth m., suppress leukotriene and histamine release in lungs, enhance mucociliary fxn, ↓microvascular permeability, inhibit phospholipase A2; COMT resistant
 Use – long-term COPD, acute bronchospasm, emergency tx for asthma
 SFx – tremor, restlessness, tachycardia, ↑plasma glucose/lactate/FFAs, ↓plasma K+
 |  | 
        |  | 
        
        | Term 
 
        | Albuterol (ventolin, salbutamol) |  | Definition 
 
        | Adrenergic agonist Mech – β2 selective agonist; relax bronchial smooth m., suppress leukotriene and histamine release in lungs, enhance mucociliary fxn, ↓microvascular permeability, inhibit phospholipase A2
 Use – acute bronchospasm, delay pre-term delivery
 SFx – tremor, restlessness, tachycardia, ↑plasma glucose/lactate/FFAs, ↓plasma K+
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic agonist Mech – β2 selective agonist; designed specifically as uterine relaxant; relax bronchial smooth m., suppress leukotriene and histamine release in lungs, enhance mucociliary fxn, ↓microvascular permeability, inhibit phospholipase A2
 Use – prolong pregnancy
 SFx – tremor, restlessness, tachycardia, ↑plasma glucose/lactate/FFAs, ↓plasma K+
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic agonist Mech – D1 selective agonist; some stimulation of α2 (inhibit NE release); renal/mesenteric/peripheral vasodilation
 Use – hypertensive crisis
 SFx – hypotension
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic agonist Mech – β1 and β2 agonist; no α activation; ↓TPR, ↑HR
 Use – bradycardia, complete heart block; CHF; ionotropic agent for MI
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic agonist Mech – primarily β1; directly acts on α1, β1, and β2; does not interfere with NE or dopamine release; +ionotrope (β1), +chronotrope, TPR unchanged (α1-β2 balance)
 Use – short-term cardiac failure; for stress tests
 SFx – excessive ↑BP and ↑HR; ventricular ectopic activity; may increase MI size; tolerance may develop
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic agonist Mech – potent α and β agonist; low dose= β1(↑PP/HR/SV/CO) β2(↓TPR, vasodilation, reflex tachycardia); moderate dose = same plus α1(↑TPR/BP); high dose = α1 predominates (↑HR/TPR, reflex bradycardia) lesser β effects
 Use – given subcutaneously with local anesthetics to limit diffusion (causes vasoconstriction); powerful cardiac stimulant (β1); relieve hypersensitivity rxns; restore heart rhythm; manage post-intubation and infectious croup; topical agent for ulcers
 SFx – in presence of β-blocker α1 effect is unopposed leading to ↑↑MAP (epi reversal phenomenon); restlessness, headaches, tremor, palpitations; cerebral hemorrhage; arrhythmias; angina in patients with CAD
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic agonist Mech – α1>>β1>>>>>β2; ↑BP/PP; ↑coronary flow; unchanged CO
 Use – limited
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic agonist Mech – acts on D1, D2, β1, α1; dopamine is especially important in regulation of movement; susceptible to MAO and COMT (can’t be given orally); low dose = D1(diuretic, renal vasodilation and ↓Na+ reasbsorption) D2(↓NE release); moderate dose = β1 predominates(↑HR/systolicBP/contractility, release of NE); high doses = α1 predominates(vasoconstriction)
 Use – for severe congestive heart failure, cardiogenic and septic shock
 SFx – hypovolemia should be corrected before use; tachycardia, angina, headache, HTN; don’t use with MAOIs or tricyclic antidepressants
 |  | 
        |  | 
        
        | Term 
 
        | Ephedrine (ephedrine, ephedra) |  | Definition 
 
        | Adrenergic agonist Mech – mixed-acting adrenoceptor agonist (indirectly release NE and directly activate adrenoceptors) mild CNS stimulant
 Use – pseudophedrine (decongestant)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic agonist Mech – indirect-acting adrenoceptor agonist; biogenic amine release, respiratory center stimulation, stimulates cortex (reduced need for rest); ↓food intake; activates peripheral α and β, ↑BP/HR; ↑urinary retention
 SFx – arrhythmias
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic agonist Mech – indirect-acting adrenoceptor agonist; can be used to make epi/NE; destroyed by MAO (tyramine-rich foods (fermented cheeses) and MAOIs cause ↓↓BP)
 |  | 
        |  | 
        
        | Term 
 
        | Prazosin / Terazosin / Doxazosin |  | Definition 
 
        | Adrenergic Antagonists Mech – α1>>>α2; ↓BP
 Use – HTN, BPH
 SFx – may cause orthostatic hypotension
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Antagonists Mech – α1>α2; irreversibly blocks α; indirect baroreflex; ↓BP and ↑HR(baroreflex)
 Use – pheochromocytoma; high catecholamine states
 SFx – orthostatic hypotension; tachycardia; myocardial ischemia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Antagonists Mech – α1=α2
 |  | 
        |  | 
        
        | Term 
 
        | Yohimbine / Rauwoscine / Torazoline |  | Definition 
 
        | Adrenergic Antagonists Mech – α2>α1; ↑sympathetic activity; ↑NE release; ↓BP with limited HR increase
 Uses – HTN
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Antagonists Mech – slightly selective for α1A; may relax prostatic smooth muscle
 Use – BPH
 SFx – may cause orthostatic hypotension
 |  | 
        |  | 
        
        | Term 
 
        | Propranolol / Nadolol / Timolol |  | Definition 
 
        | Adrenergic Antagonists Mech – blocks β1 and β2 (β1=β2); ↓HR/BP/rennin
 Use – HTN, angina, arrhythmias, migraine, hyperthyroidism
 SFx – bradycardia, worsened asthma, fatigue, cold hands, vivid dreams
 |  | 
        |  | 
        
        | Term 
 
        | Metoprolol / Atenolol / Aloprenolol / Betaxolol / Nebivolol (AMEBA) |  | Definition 
 
        | Adrenergic Antagonists Mech – block β1 > β2; ↓HR/BP/rennin
 Use – angina, HTN, arrhythmias
 SFx – bradycardia, fatigue, vivid dreams, cold hands (may avoid asthma)
 |  | 
        |  | 
        
        | Term 
 
        | Pindolol / Acebutolol / Carteolol / Penbutolol |  | Definition 
 
        | Adrenergic Antagonists Mech – block β1 and β2 with ISA (intrinsic symp. activity); ↓BP and modestly ↓HR
 Use – HTN, arrhythmias, migraine
 SFx – fatigue, vivid dreams, cold hands (avoid bradycardia)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Adrenergic Antagonists Mech – block β > α1
 Use – heart failure
 SFx – fatigue
 |  | 
        |  |